510(k) Report

PMA · Approved

Approved

Amplicor (TM) Mycobacterium Tuberculosis Test

P940040PMAApproved Nov 26, 1996705-day reviewClass II21 CFR 866.3372

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Molecular Systems, Inc. · MWA System, Nucleic Acid Amplification, Mycobacterium Tuberculosis Complex

Approved on Nov 26, 1996 through premarket approval, which rests on the device’s own clinical evidence after a 705-day review.

Decided
Nov 26, 1996
Review
705 days
Class
Class II
Product code
MWA
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P940040 has 9 supplements since 2000: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2000: 12004: 22005: 22007: 12008: 3
2000high 3 (2008) · low 0 (2001)2008
View FIG. 1 as a table
YearSupplements approved
20001
20042
20052
20071
20083
FIG. 1 — Supplements to P940040, 2000–2008Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MWA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All MWA devices

MWA System, Nucleic Acid Amplification, Mycobacterium Tuberculosis Complex: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MWA

1in 2012

2007: 22008: 32010: 12012: 1
2007high 3 (2008) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MWA

Too few MWA 510(k)s in any year since 2007 to give a median.

Recalls per year · MWA

1in 2012

2012: 1
2007high 1 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MWA

No MAUDE report names MWA since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20083—00
20090—00
20101—00
20110—00
20121—10
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—
Cite this page

510(k) Report. “P940040: Amplicor (TM) Mycobacterium Tuberculosis Test.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P940040

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026